Cite
HARVARD Citation
Dréanic, J. et al. (2015). Anti‐epidermal or anti‐vascular endothelial growth factor as first‐line metastatic colorectal cancer in modified Glasgow prognostic score 2' patients. Journal of cachexia, sarcopenia and muscle. 6 (3), pp. 231-236. [Online].